Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Culver

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Archives of Internal Medicine|January 11, 2012
Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health InitiativeAnnie L Culver, Ira S Ockene, Raji Balasubramanian, et al.
Science Advances|September 13, 2021
Cell-free DNA TAPS provides multimodal information for early cancer detectionPaulina Siejka-Zielińska, Jingfei Cheng, Felix Jackson, et al.
American Journal of Public Health|June 15, 2013
Relations of depressive symptoms and antidepressant use to body mass index and selected biomarkers for diabetes and cardiovascular diseaseYunsheng Ma, Raji Balasubramanian, Sherry L Pagoto, et al.
Alimentary Pharmacology & Therapeutics|September 22, 2025
Non-Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary CholangitisNadir Abbas, Rachel Smith, Ellina Lytvyak, et al.
Clinical Medicine (London, England)|May 17, 2020
Experience from the first UK inter-regional specialist multidisciplinary meeting in the diagnosis and management of IgG4-related diseaseGeorge Goodchild, Rory Jr Peters, Tamsin N Cargill, et al.
European Journal of Immunology|April 15, 2020
Divergent chemokine receptor expression and the consequence for human IgG4 B cell responsesPeter-Paul A Unger, Laura C Lighaam, Ellen Vermeulen, et al.
Liver Cancer|May 8, 2025
Current Surveillance Strategy Is Less Effective for Detecting Early-Stage Hepatocellular Carcinoma in Patients with Non-Viral and Non-Cirrhotic Liver DiseaseJessica Spiers, Wenhao Li, Aloysious D Aravinthan, et al.
Clinical and Experimental Rheumatology|March 3, 2022
Blood biomarkers recommended for diagnosing and monitoring IgG4-related disease. Considerations from the ERN ReCONNET and collaborating partnersLuca Iaccarino, Rosaria Talarico, Emanuele Bozzalla-Cassione, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 12, 2022
UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary CholangitisNadir Abbas, Emma L Culver, Douglas Thorburn, et al.
Nature Reviews. Gastroenterology & Hepatology|February 19, 2026
The ethics of unlicensed therapy use in primary biliary cholangitis: a counter viewDavid E J Jones, Robert Mitchell-Thain, Emma L Culver, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Archives of Internal Medicine|January 11, 2012
Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health InitiativeAnnie L Culver, Ira S Ockene, Raji Balasubramanian, et al.
Science Advances|September 13, 2021
Cell-free DNA TAPS provides multimodal information for early cancer detectionPaulina Siejka-Zielińska, Jingfei Cheng, Felix Jackson, et al.
American Journal of Public Health|June 15, 2013
Relations of depressive symptoms and antidepressant use to body mass index and selected biomarkers for diabetes and cardiovascular diseaseYunsheng Ma, Raji Balasubramanian, Sherry L Pagoto, et al.
Alimentary Pharmacology & Therapeutics|September 22, 2025
Non-Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary CholangitisNadir Abbas, Rachel Smith, Ellina Lytvyak, et al.
Clinical Medicine (London, England)|May 17, 2020
Experience from the first UK inter-regional specialist multidisciplinary meeting in the diagnosis and management of IgG4-related diseaseGeorge Goodchild, Rory Jr Peters, Tamsin N Cargill, et al.
European Journal of Immunology|April 15, 2020
Divergent chemokine receptor expression and the consequence for human IgG4 B cell responsesPeter-Paul A Unger, Laura C Lighaam, Ellen Vermeulen, et al.
Liver Cancer|May 8, 2025
Current Surveillance Strategy Is Less Effective for Detecting Early-Stage Hepatocellular Carcinoma in Patients with Non-Viral and Non-Cirrhotic Liver DiseaseJessica Spiers, Wenhao Li, Aloysious D Aravinthan, et al.
Clinical and Experimental Rheumatology|March 3, 2022
Blood biomarkers recommended for diagnosing and monitoring IgG4-related disease. Considerations from the ERN ReCONNET and collaborating partnersLuca Iaccarino, Rosaria Talarico, Emanuele Bozzalla-Cassione, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 12, 2022
UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary CholangitisNadir Abbas, Emma L Culver, Douglas Thorburn, et al.
Nature Reviews. Gastroenterology & Hepatology|February 19, 2026
The ethics of unlicensed therapy use in primary biliary cholangitis: a counter viewDavid E J Jones, Robert Mitchell-Thain, Emma L Culver, et al.
Pageof 12